1. Corporate Officers - K
2. Kango Sujay

Insider Trading History of Kango Sujay

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Kango Sujay since 2016. This trader's CIK number is 1336503. At the time of last reporting, Kango Sujay was the EVP, Chief Commercial Officer of Acceleron Pharma Inc. (stock ticker symbol XLRN). Also see all insider trading activities at Acceleron Pharma Inc.

Note that in the past KANGO SUJAY also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Infinity Pharmaceuticals, Inc. (INFI) by Kango Sujay

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2016	INFI	0	$0	75,000	$96,299	0	$0

Yearly summary of insider trading at Acceleron Pharma Inc (XLRN) by Kango Sujay

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2021	XLRN	0	$0	25,000	$3,559,620	15,000	$609,150
2020	XLRN	0	$0	480	$24,633	0	$0

Insider trading activities at 2 companies by Kango Sujay:

1. Infinity Pharmaceuticals, Inc. (INFI)

2. Acceleron Pharma Inc (XLRN)

Table 1. Insider trading of Infinity Pharmaceuticals, Inc. (INFI) by Kango Sujay

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2016-12-13	INFI	Sale	49,991	1.27	63,688
2016-12-12	INFI	Sale	25,009	1.30	32,611

Table 2. Insider trading of Acceleron Pharma Inc (XLRN) by Kango Sujay

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2021-09-27	XLRN	Option Ex	5,000	40.61	203,050
2021-09-27	XLRN	Sale	5,000	175.00	875,000
2021-09-21	XLRN	Option Ex	5,000	40.61	203,050
2021-09-21	XLRN	Sale	5,000	150.03	750,150
2021-03-02	XLRN	Option Ex	5,000	40.61	203,050
2021-03-02	XLRN	Sale	5,000	136.75	683,740
2021-01-04	XLRN	Sale	10,000	125.07	1,250,730
2020-01-03	XLRN	Sale	480	51.32	24,633

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kango Sujay (EVP, Chief Commercial Officer of Acceleron Pharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month